Related Experiment Video
Updated: Mar 11, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Platelets in liver and renal disease.
1Divisions of Hematology, Departments of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
This review examines how kidney and liver diseases affect platelet count and function. It explores the link between low platelets (thrombocytopenia) and bleeding risk, and platelets' active role in disease.
Area of Science:
- Hematology
- Nephrology
- Hepatology
Background:
- Renal and liver diseases are common and serious conditions.
- Platelet count and function are often altered in these diseases.
- Thrombocytopenia is a frequent complication.
Purpose of the Study:
- To review how renal and liver diseases impact platelet number and function.
- To assess the correlation between thrombocytopenia and bleeding risk.
- To discuss the emerging evidence of platelets' active role in disease pathobiology.
Main Methods:
- Literature review of existing studies.
- Analysis of data on platelet count, function, and bleeding complications.
- Synthesis of emerging research on platelet involvement in disease.
Main Results:
- Renal and liver diseases significantly alter platelet count and function.
- The relationship between low platelet count and bleeding risk is complex and requires further investigation.
- Platelets are increasingly recognized as active participants in the pathogenesis of these diseases.
Conclusions:
- Platelet abnormalities are a key feature of renal and liver disease.
- Understanding platelet behavior is crucial for managing bleeding risks.
- Further research into the novel roles of platelets may reveal new therapeutic targets.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.